SCHEDULE: Jorey Chernett Boosts Airsculpt Stake to 10.79%

Jorey Chernett has increased beneficial ownership in Airsculpt Technologies, Inc. to 10.79% of common stock.

Summary

• Jorey Chernett, the Reporting Person, beneficially owns 6,781,811 shares of Airsculpt Technologies, Inc. Common Stock.
• This represents 10.79% of the outstanding shares of the company.
• The calculation is based on 62,436,670 shares outstanding as of November 6, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q, plus shares underlying currently exercisable call options.
• Chernett holds sole voting power and sole dispositive power over these shares.
• This filing is an Amendment No. 2 to a Schedule 13G, indicating a change in beneficial ownership previously reported.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant increase in an individual's beneficial ownership to over 10% often reflects confidence in the company's future performance or valuation.

Positives

• A significant individual investor, Jorey Chernett, has increased their stake to over 10%, indicating confidence in Airsculpt Technologies, Inc.
• The investor holds sole voting and dispositive power over their substantial holding, suggesting direct influence.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that an individual investor increasing their stake to over 10% in a company like Airsculpt Technologies, which operates in the elective cosmetic surgery sector, could signal a belief in the company's growth prospects or undervaluation. This level of ownership often warrants closer attention from other market participants, as it represents a significant vote of confidence from a single entity.

Stakeholder Impact

• Shareholders: Increased confidence due to a significant individual investor taking a large stake, potentially signaling positive future performance.
• Company Management: May experience increased scrutiny or support from a substantial shareholder, potentially influencing strategic decisions.

Key Dates

Recommendation

While the increased stake by Jorey Chernett to 10.79% is a positive signal of confidence, a Schedule 13G filing primarily discloses ownership and does not provide sufficient operational or financial details to warrant a 'buy' or 'sell' recommendation. It suggests a 'hold' as investors should monitor for further developments or rationale behind this significant accumulation.

Keywords

Airsculpt Technologies, Jorey Chernett, Schedule 13G, Common Stock, Beneficial Ownership, Shareholder, Equity Stake, SEC Filing, 009496100